3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Infections, Parvoviridae in 1 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, IR | 1 |
| Kaowinn, S | 1 |
| Moon, J | 1 |
| Soh, J | 1 |
| Kang, HY | 1 |
| Jung, CR | 1 |
| Oh, S | 1 |
| Song, H | 1 |
| Koh, SS | 1 |
| Chung, YH | 1 |
1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Infections, Parvoviridae
| Article | Year |
|---|---|
Oncotropic H-1 parvovirus infection degrades HIF-1α protein in human pancreatic cancer cells independently of VHL and RACK1.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; GTP-Binding Proteins; H-1 parvovirus; Hu | 2015 |